Acurx Pharmaceuticals Inc (ACXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,967 | -14,103 | -14,578 | -12,093 | -12,748 |
| Other Working Capital | -394 | 206 | 1,140 | 1,248 | 141 |
| Other Operating Activity | 1,572 | 3,514 | 3,637 | 3,302 | 7,593 |
| Operating Cash Flow | $-6,788 | $-10,383 | $-9,801 | $-7,542 | $-5,014 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,808 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 6,829 | 6,616 | 8,163 | 3,695 | 14,797 |
| Financing Cash Flow | $10,637 | $6,616 | $8,163 | $3,695 | $14,797 |
| Beginning Cash Position | 3,707 | 7,474 | 9,112 | 12,959 | 3,175 |
| End Cash Position | 7,556 | 3,707 | 7,474 | 9,112 | 12,959 |
| Net Cash Flow | $3,849 | $-3,768 | $-1,638 | $-3,847 | $9,783 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,788 | -10,383 | -9,801 | -7,542 | -5,014 |
| Free Cash Flow | -6,788 | -10,383 | -9,801 | -7,542 | -5,014 |